Stay updated on Efficacy of Rifaximin with NAC in IBS-D Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page.

Latest updates to the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's revision label updated from v3.5.3 to v3.5.4, indicating an internal update to the study record display.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page’s footer updated the displayed software/version revision from **v3.5.2** to **v3.5.3**. This represents an administrative release or UI update rather than a change to the clinical trial details.SummaryDifference0.0%

- Check39 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision: v3.4.3 added and Revision: v3.4.2 removed. No visible changes to study content or functionality are indicated.SummaryDifference0.0%

- Check103 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-status notice and the older Revision: v3.4.1 from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Efficacy of Rifaximin with NAC in IBS-D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page.